Hereditary Breast and Ovarian Cancer syndrome (HBOC) is an inherited genetic condition that increases the risk for breast, ovarian and other cancers. Inherited conditions are passed to a person by their parents. Although most cancers are not inherited, about 5% to 10% of people who have breast cancer and about 15% of women who have ovarian cancer have HBOC. Gene changes (mutations) in the BRCA1 and BRCA2 genes cause HBOC.
What are the cancer risks for people with HBOC?
HBOC places a person at higher risk for developing:  A higher than usual risk of developing breast cancer (40% to 87% lifetime risk)*  A higher than usual risk of breast cancer that occurs before age 50, or before a woman reaches menopause  An increased risk of developing a second primary breast cancer (15% to 60% risk)  A higher than usual risk of developing ovarian cancer (10% to 44% lifetime risk)**  The risk of breast cancer in men is higher than usual (6% lifetime risk)  Prostate cancer that occurs at younger ages than in the general population. Men at risk should discuss the benefits, risks and limitations of prostate cancer screening with their doctor  Other cancers, including pancreatic cancer and melanoma 
What are my chances of inheriting HBOC?
Each person has two copies of all genes, including the BRCA1/2 genes. One copy is inherited from the mother, and one copy is inherited from the father. One inherited gene mutation in either copy of a BRCA gene will cause HBOC. There is a 50% chance that a person with HBOC will pass the change or mutation to each of their children. Inheriting this mutation causes an increased risk for several types of cancers (refer to page 1). If a person does not have the mutation, they may have about the same risk for breast and ovarian cancer as others in the general population.
The risk is about a 12% lifetime risk for breast cancer and about a 1% to 2% lifetime risk for ovarian cancer.
Why is it important to diagnose HBOC?
People who have HBOC are at much higher risk for breast, ovarian and other cancers than people in the general population. For someone who has cancer, the diagnosis of HBOC may also mean a higher risk of developing a new cancer in the future. For these reasons, people with HBOC should follow different screening and prevention guidelines than people at average risk. Following the early detection and prevention guidelines for people with HBOC can reduce these cancer risks.
Because HBOC is inherited, this affects the entire family. If genetic testing finds the specific mutation causing HBOC in one person, other family members may also need to be tested.
How is HBOC diagnosed?
Family History A review of medical and family history is used to screen for HBOC. A genetic counselor usually conducts this screening and assesses the risk for HBOC. During the screening, the patient and counselor create a multi-generation family tree.  Ashkenazi Jewish ancestry
Testing may be needed if the medical and family history suggests the possibility of HBOC.
Genetic Testing for HBOC
Genetic testing of a blood or saliva sample can find a mutation in the BRCA1 or BRCA2 gene. If a mutation is found, then the HBOC diagnosis is confirmed. Other family members may have a genetic test to learn whether or not they carry the same mutation and also have increased cancer risks.
Sometimes, genetic testing will not find a mutation in the BRCA1 or BRCA2 genes even in persons with a clinical history that suggests HBOC. This does not always mean that they do not have HBOC. Current genetic testing technology is not able to identify all mutations or other genes that may cause HBOC.
Another result that is possible is called a variant of uncertain significance (VUS). This is a gene change that does not provide clear information about cancer risks. In these cases, further testing may be ordered to help clarify the result.
Genetic Testing for Relatives
People who have a BRCA1/2 mutation, inherited it from either their father or mother. There is a 50/50 (1 in 2) chance of passing the mutation to each of their children. BRCA1and BRCA2 mutations do not skip generations and both men and women are equally likely to inherit or pass down the mutation.
At-risk relatives may decide to do genetic testing to check for the mutation. This may help determine who needs to adjust their cancer screening and prevention options. If a person did not inherit the BRCA1/2 mutation, their family history of cancer is used to make screening recommendations.
In rare cases when both parents have a BRCA2 mutation, their child has a risk for inheriting two BRCA2 mutations. Someone who has two BRCA2 mutations (one inherited from each parent) has a different genetic condition called Fanconi Anemia. This is a rare childhood blood disorder that causes bone marrow failure, physical changes and increased blood cancer risks. People with a BRCA1/2 mutation may want to talk with their partner about testing for the mutation before having children.
How is HBOC managed?
It is very important for people with HBOC to reduce their cancer risk by following specific cancer prevention and early detection guidelines. Cancer screening exams, and/or preventive surgery are tailored to each patient and their family by a team of specialists. Cancer screening exams are medical tests performed to ensure that any existing cancers are found at their earliest, most treatable stages. See page 4 for general screening and prevention guidelines for people with HBOC. 
Ovarian Cancer Symptoms
Ovarian cancer symptoms are not very specific. Other common conditions can also cause the same symptoms. This can make it hard to find ovarian cancer by symptoms alone. Talk with your doctor if you have symptoms that will not go away or if you have new symptoms. Symptoms to watch for include:  Swelling or bloating of the abdomen  Feeling of pain or pressure in the pelvic area  Change in appetite  Feeling full after eating only a small amount  Changes in bowel or bladder habits (such as urgency to urinate or frequency of urination)
